Cegedim S.A. | Small-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2016

Income Metrics

Revenue 122.5M
Gross Profit 76.2M 62.17%
Operating Income 11.8M 9.64%
Net Income -10.0M -8.13%

Balance Sheet Metrics

Total Assets 986.9M
Total Liabilities 704.4M
Shareholders Equity 282.5M
Debt to Equity 2.49

Cash Flow Metrics

Operating Cash Flow 7.2M
Free Cash Flow 9.9M

Revenue & Profitability Trend

Cegedim S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i654.5M616.0M555.2M524.7M496.9M
Cost of Goods Sold i29.6M28.5M81.4M84.3M73.2M
Gross Profit i624.9M587.4M473.8M440.4M423.8M
Gross Margin % i95.5%95.4%85.3%83.9%85.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-47.0M37.7M27.3M29.9M
Other Operating Expenses i153.1M146.6M20.1M10.9M27.4M
Total Operating Expenses i153.1M193.6M57.9M38.2M57.3M
Operating Income i39.6M32.4M14.5M37.2M24.9M
Operating Margin % i6.1%5.3%2.6%7.1%5.0%
Non-Operating Items
Interest Income i1.6M475.0K114.0K90.0K75.0K
Interest Expense i17.9M11.7M8.9M8.4M8.5M
Other Non-Operating Income-----
Pre-tax Income i-9.8M8.1M17.7M33.3M13.2M
Income Tax i5.8M14.8M4.6M5.8M2.0M
Effective Tax Rate % i0.0%183.2%26.0%17.5%14.9%
Net Income i-15.1M-7.9M12.1M26.3M10.9M
Net Margin % i-2.3%-1.3%2.2%5.0%2.2%
Key Metrics
EBITDA i127.3M118.0M115.5M107.2M104.6M
EPS (Basic) i--€0.50€1.00€1.90€0.80
EPS (Diluted) i--€0.50€1.00€1.90€0.80
Basic Shares Outstanding i-13610429136583481378243613824493
Diluted Shares Outstanding i-13610429136583481378243613824493

Income Statement Trend

Cegedim S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i49.6M46.6M55.6M24.2M24.7M
Short-term Investments i----1.0K
Accounts Receivable i186.0M175.2M151.8M136.3M134.6M
Inventory i6.7M5.5M6.5M4.5M3.8M
Other Current Assets-----
Total Current Assets i363.1M329.1M300.4M232.7M370.5M
Non-Current Assets
Property, Plant & Equipment i137.8M139.0M119.7M111.5M98.3M
Goodwill i662.9M593.8M585.6M554.1M535.1M
Intangible Assets i191.4M194.2M188.1M179.9M163.0M
Long-term Investments-----
Other Non-Current Assets-2.0K1.0K--1.0K
Total Non-Current Assets i623.8M594.9M589.5M564.9M534.9M
Total Assets i986.9M924.1M889.9M797.6M905.4M
Liabilities
Current Liabilities
Accounts Payable i71.8M61.7M55.7M48.2M43.2M
Short-term Debt i14.1M14.8M15.9M16.1M17.8M
Current Portion of Long-term Debt-----
Other Current Liabilities139.9M669.0K202.0K282.0K227.0K
Total Current Liabilities i366.2M323.1M287.1M263.7M403.3M
Non-Current Liabilities
Long-term Debt i301.4M78.8M75.9M70.3M248.6M
Deferred Tax Liabilities i1.7M5.6M6.1M8.3M7.6M
Other Non-Current Liabilities---1.0K-1.0K
Total Non-Current Liabilities i338.2M306.4M298.7M301.5M294.1M
Total Liabilities i704.4M629.5M585.8M565.2M697.5M
Equity
Common Stock i13.4M13.3M13.3M13.3M13.3M
Retained Earnings i254.0M-7.4M13.6M26.2M10.8M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i282.5M294.6M304.1M232.4M207.9M
Key Metrics
Total Debt i315.5M93.6M91.8M86.4M266.5M
Working Capital i-3.1M6.1M13.3M-31.0M-32.8M

Balance Sheet Composition

Cegedim S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-15.1M-7.9M12.1M26.3M10.9M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i0-20.3M-22.7M32.6M8.5M
Operating Cash Flow i5.7M-16.4M-1.8M69.3M28.0M
Investing Activities
Capital Expenditures i-26.3M-19.4M-15.5M668.0K11.0M
Acquisitions i-36.9M-3.4M52.5M-5.1M-7.1M
Investment Purchases i0-1.0M-2.6M-3.9M-1.8M
Investment Sales i4.8M888.0K1.6M2.0M40.0K
Investing Cash Flow i-58.4M-22.9M35.3M-6.3M2.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i---6.8M--
Debt Issuance i180.0M0000
Debt Repayment i-136.4M-263.0K-85.0K-1.2M-20.2M
Financing Cash Flow i39.4M-6.2M-9.8M-356.0K-19.1M
Free Cash Flow i11.9M22.4M10.3M45.2M55.8M
Net Change in Cash i-13.2M-45.5M23.7M62.6M11.1M

Cash Flow Trend

Cegedim S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 92.86
Forward P/E 6.84
Price to Book 0.54
Price to Sales 0.22
PEG Ratio 6.84

Profitability Ratios

Profit Margin -2.25%
Operating Margin 8.56%
Return on Equity -4.95%
Return on Assets 2.46%

Financial Health

Current Ratio 0.99
Debt to Equity 115.34
Beta 1.03

Per Share Data

EPS (TTM) -€1.10
Book Value per Share €19.28
Revenue per Share €47.75

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
cgm143.2M92.860.54-4.95%-2.25%115.34
Equasens 772.6M16.533.3416.13%16.72%25.65
Abl Diagnostics 86.8M535.0011.514.00%4.86%34.10
Smaio S.A 36.9M16.304.98-29.15%-42.73%33.75
Intrasense S.A 15.2M-9.16-126.47%-251.78%84.95
Ama Corp Plc 14.4M-5.72-176.91%-294.90%159.28

Financial data is updated regularly. All figures are in the company's reporting currency.